In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides

被引：40
作者：
Cercenado, E [1 ]
Cercenado, S [1 ]
Gómez, JA [1 ]
Bouza, E [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Microbiol Serv, Madrid 28007, Spain
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 52卷 / 01期
关键词：
tigecycline; GAR-936; glycopeptide-resistant enterococci; glycopeptide-resistant staphylococci; Gram-positives;
D O I：
10.1093/jac/dkg289
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 6 条
  • [1] In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain
    Betriu, C
    Rodríguez-Avial, I
    Sánchez, BA
    Gómez, M
    Alvarez, J
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 892 - 895
  • [2] In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria
    Boucher, HW
    Wennersten, CB
    Eliopoulos, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2225 - 2229
  • [3] Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates
    Milatovic, D
    Schmitz, FJ
    Verhoef, J
    Fluit, AC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 400 - 404
  • [4] National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
  • [5] In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)
    Petersen, PJ
    Jacobus, NV
    Weiss, WJ
    Sum, PE
    Testa, RT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 738 - 744
  • [6] In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens
    Petersen, PJ
    Bradford, PA
    Weiss, WJ
    Murphy, TM
    Sum, PE
    Projan, SJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2595 - 2601
1